Navigation Links
Cancer Therapy & Research Center at The University of Texas Health Science Center and Oncolytics Biotech(R) Inc. Announce Multi-Trial Clinical Research Collaboration
Date:2/4/2009

CALGARY, Feb. 4 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY) and the Cancer Therapy & Research Center at The University of Texas Health Science Center in San Antonio, (CTRC at UTHSCSA) announced a broad preclinical and clinical collaboration involving up to five, open-label, Phase 2 studies exploring the use of REOLYSIN(R) in combination with chemotherapy for various cancer indications. These indications are expected to include melanoma, pancreatic cancer, squamous cell lung, liver and K-RAS mutated colorectal cancers in combination with standard chemotherapeutics. This research program is in addition to Phase 2 trials in sarcoma and refractory head & neck cancers, sponsored by Oncolytics that are currently underway at this site.

"As an NCI-designated cancer center, we give a very high priority to approaches that are likely to significantly improve the prognosis of patients with malignant diseases," said Dr Giles, Deputy Director of the CTRC at UTHSCSA. "As Director of our Institute for Drug Development (IDD), I am pleased to specifically dedicate IDD resources toward the further rapid investigation of REOLYSIN(R), an agent which is proving itself in the clinic."

"We're excited that an institution of this caliber is investing in additional research opportunities for REOLYSIN(R)," said Dr. Karl Mettinger, Chief Medical Officer of Oncolytics. "This comprehensive research program will explore additional opportunities for REOLYSIN(R) in cancer treatment, while allowing the Company to focus its resources on developing its pivotal program."

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I a
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. VIDEO from Medialink and International HIFU: New Prostate Cancer Procedure Being Tested in US Clinical Trials
2. Society of Gynecologic Oncologists 40th Annual Meeting on Womens Cancer to Include Sessions on Robotics Surgery
3. Winning the War on Cancer: The Critical Role of Radiation Oncology
4. Oncolytics Biotech Inc. Announces Start of Patient Enrolment in Translational Clinical Trial Investigating REOLYSIN(R) in Patients with Metastatic Colorectal Cancer
5. Research Teams at J. Craig Venter Institute and Ludwig Institute for Cancer Research Uncover New Chromosomal Alterations in Cancer Using Transcriptome Sequencing Approach
6. Pivotal Data Published For First Biomarker Combination Test to Determine Risk of Ovarian Cancer in Women Who Present With Pelvic Mass
7. ThromboGenics and BioInvent Receive Technology Transfer Success Fee From Roche for the Novel Anti-Cancer Antibody, TB-403 (Anti-PIGF)
8. Immunomedics Announces Preclinical Therapy Results of SN-38 Immunoconjugate for Colorectal Cancer
9. Chemoembolization Improving as Liver Cancer Treatment
10. A Milestone in Cancer Genetics: deCODE Discovers First Common Genetic Variants Affecting the Risk of Many Types of Cancer
11. Algeta Completes Comprehensive Phase II Clinical Program With Alpharadin for Treating Bone Metastases in Patients With Advanced Prostate Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)... Royal Philips Electronics ( PHG, A...ry need by showing its portfolio of products desig...nnual meeting of the Radiological Society of North...ilips are several advancements and upgrades focuse...nd streamlining workflow to expand upon clinical c...
(Date:11/29/2009)...ewswire/ -- FUJIFILM Medical Systems USA, Inc. is ...y flat panel DR cassette, at the 2009 Radiological...Ideal for any clinical environment, FDR D-EVO uses...s with Fujifilm,s trademark image quality and outs...for users to transition to DR without modification...
(Date:11/29/2009)...ewswire/ -- Stimulated by the ten years of Synapse... Systems USA announced today, at the Radiological ...e formation of its Medical Informatics Division ....up will integrate all functions associated with th...tform for future growth. ,, Several organizatio...
Breaking Medicine Technology:Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 2Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 3Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 4Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 5FUJIFILM's DR Cassette Makes World Debut 2FUJIFILM Establishes Medical Informatics Organization 2FUJIFILM Establishes Medical Informatics Organization 3Par Pharmaceutical Announces Results of Its Modified Dutch Auction Tender Offer 62113 1Par Pharmaceutical Announces Results of Its Modified Dutch Auction Tender Offer 62113 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 1Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 9Abaxis Inc to Present at the 21st Annual Piper Jaffray Health Care Conference 6535 1
...ov. 5 CANTEL MEDICAL,CORP. (NYSE: CMN ), through...rest from schools for its hand sanitization and su...reported incidence of MRSA,(Methicillin-resistant ... to R. Scott Jones, Cantel Medical,s President & C...als helping them respond to the,growing threat of ...
...tech Pharmaceuticals,Inc. (Amex: IMM ) today anno...entific consortium led by the University of North ...s from The Bill & Melinda Gates Foundation,(the "G...frican sleeping,sickness (trypanosomiasis) and lei...he Gates Foundation has granted to the UNC-led con...
Other Medicine Technology:Cantel Medical Corp.'s Crosstex Subsidiary Addresses School MRSA Concerns With SaniTyze(TM) Brand Hand Sanitizer and Sanitex(R) Surface Disinfecting Line of Products 2Cantel Medical Corp.'s Crosstex Subsidiary Addresses School MRSA Concerns With SaniTyze(TM) Brand Hand Sanitizer and Sanitex(R) Surface Disinfecting Line of Products 3Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials 2Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials 3
(Date:11/27/2009)... , NEUILLY-SUR-SEINE, France, Nov. 27 /PRN...ican professional cycling team dedicated to ethica...ycling champions, announced today that it will bec...ransitions Optical as a new sponsor of the team. T...urer of adaptive eyewear, offering the most advanc...
(Date:11/27/2009)... XenaCare Holdings has annou...Arthritis Foundation, one of the largest nonprofit... public health education. , ...enaCare Holdings, Inc. (OTCBB: XCHO), a company sp...n of consumer healthcare products, has announced t...
(Date:11/27/2009)...ring rates to bring unprecedented medical, economi...v. 27 (HealthDay News) -- The number of people wit...ble over the next 25 years, a new study predicts. ...4.1 million people with the disease, up from 23.7 ... treating people with diabetes will triple, the st...
(Date:11/27/2009)... Voyant Health™ announ...igan) has licensed its TraumaCad Enterprise orthop...workflow solution. , (PRW...unced today that Spectrum Health (Grand Rapids, Mi...opedic templating solution and its TraumaCad Exten...
(Date:11/27/2009)... Specialist manufacturers wh...ducts are saving millions of dollars by bringing i...rocess. Increasing numbers of pro-active medical m...rts at the concept stage of their projects, ensuri...ng design processes or potentially outdated techno...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4
...patients choose to leave the hospital before the t...uences may involve risk of inadequately treated me...ording to a review in the March 2009 issue of May...rove this important issue. , Although studies to ...
... the international journal Chest , by Neil Eves, ...lmonary disease (COPD) who breathed a mix of 60% h...am were able to exercise longer and harder than th...eater improvements in fitness also get better impr...
..., 2009Chemicals present in cranberriesand not the ...revent infection-causing bacteria from attaching t...nted in a report published in Journal of Medicina...om/jmf , Urinary tract infections (UTIs) burden ...
...rovide Information on Medicare Advantage Special N...Market , , ST. LOUIS, March 9 A series of free s...iaries with chronic illness maintain a healthy lif...hout the state. , , Care Improvement Plus, the s...
...es company for continued growth , , ATLANTA, Marc... today announced it has grown to 275 customers and...ents, Reveille positions itself for continued mark...ience and Performance Manager (EPM), enables custo...
...M study show continued, significant relief of depr...her rates of hospitalization and death among ESRD ...dical, Inc. (Nasdaq: NXTM ), a leading manufactu...ion in depressive symptoms experienced by patients...
Other Medicine News:Health News:Patients being discharged against medical advice 2Health News:Helium helps lung patients breathe easier 2Health News:New research reveals how cranberry products prevent urinary tract infections 2Health News:Seminars Offered to Missouri Seniors With Diabetes and Other Chronic Illnesses 2Health News:Reveille Software Reaches Customer Milestone and Expands Executive Team 2Health News:Reveille Software Reaches Customer Milestone and Expands Executive Team 3Health News:NxStage Reports Sustained Reduction in Clinical Depressive Symptoms for Daily Home Hemodialysis Patients After One Year 2Health News:NxStage Reports Sustained Reduction in Clinical Depressive Symptoms for Daily Home Hemodialysis Patients After One Year 3Health News:NxStage Reports Sustained Reduction in Clinical Depressive Symptoms for Daily Home Hemodialysis Patients After One Year 4
Finnpipette Fixed Volume, 1ul
...es 2000 Pipette is a synonym for pipetting accurac...nd superior operating comfort. Its single, multifu...troke and blow-out as well as eject the tip. Produ... utmost accuracy and precision. Ejection sleeve ca...
...es 2000 Pipette is a synonym for pipetting accurac...nd superior operating comfort. Its single, multifu...troke and blow-out as well as eject the tip. Produ... utmost accuracy and precision. Ejection sleeve ca...
Finnpipette Focus Fixed Volume, 2ul
Medicine Products: